Cefazolin sodium powder for injection

Therapeutic indications
indicated in the treatment of the following serious infections due to susceptible
organisms:
Respiratory Tract Infection: Due to S. pneumoniae, Klebsiella sp, H. influenzae, Staph, aureus (including penicillinase-producing strains), and Group A β-haemolytic streptococci.
Genitourinary Tract Infections: Due to E. coli, P. mirabilis, Klebsiella sp., and some strains of Enterobacter and enterococci.
Skin and Soft-tissue Infections: Due to Staph. aureus (including penicillinase-producing strains) and Group A β- haemolytic streptococci and other strains of streptococci.
Biliary Tract Infections: Due to E. coli, various strains of streptococci, P. mirabilis, Klebsiella sp., and Staph. aureus.
Bone and Joint Infections: Due to Staph. Aureus
Septicaemia: Due to S. pneumoniae, Staph. aureus (penicillin-susceptible and penicillin-resistant). P. mirabilis, E. coli, and Klebsiella sp.
Endocarditis: Due to Staph. aureus (penicillin-susceptible and penicillin-resistant) and Group A β- haemolytic streptococci.
Perioperative Prophylaxis:
Dose and method of administration
Cefazolin may be administered intramuscularly or intravenously after reconstitution. Total
daily dosag
Intramuscular Administration:
Shake well until dissolved. The 500 mg vial can be reconstituted with 0.9% Sodium Chloride Injection, Sterile Water for Injection or Bacteriostatic Water for Injection.
ntravenous Administration:
Cefazolin may be administered by intravenous injection or by continuous or intermittent
infusion.

****Follow all directions given to you by your doctor and pharmacist carefully
 

Since 2015, NINGBO VOICE BIOCHEMIC CO. LTD. is a professional company to offer one-package service for FPP (Finished Pharmaceutical Products ); APIs (Active Pharmaceutical Ingredients); Chemicals (Pharmaceutical Intermediates ); Veterinary Pharmaceuticals.that meet requirements of Standard GMP and current BP,USP version.

We will spare no efforts to meet your demands!